Annual Revenue
$33.88 M
-$9.23 M-21.41%
December 31, 2023
Summary
- As of March 10, 2025, CASI annual revenue is $33.88 million, with the most recent change of -$9.23 million (-21.41%) on December 31, 2023.
- During the last 3 years, CASI annual revenue has risen by +$18.74 million (+123.76%).
- CASI annual revenue is now -21.41% below its all-time high of $43.11 million, reached on December 31, 2022.
Performance
CASI Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$7.79 M
+$3.81 M+95.85%
September 1, 2024
Summary
- As of March 10, 2025, CASI quarterly revenue is $7.79 million, with the most recent change of +$3.81 million (+95.85%) on September 1, 2024.
- Over the past year, CASI quarterly revenue has stayed the same.
- CASI quarterly revenue is now -48.93% below its all-time high of $15.26 million, reached on December 31, 2022.
Performance
CASI Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$22.05 M
-$1.04 M-4.52%
September 1, 2024
Summary
- As of March 10, 2025, CASI TTM revenue is $22.05 million, with the most recent change of -$1.04 million (-4.52%) on September 1, 2024.
- Over the past year, CASI TTM revenue has stayed the same.
- CASI TTM revenue is now -49.46% below its all-time high of $43.64 million, reached on June 30, 2023.
Performance
CASI TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
CASI Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -21.4% | 0.0% | 0.0% |
| 3 y3 years | +123.8% | 0.0% | 0.0% |
| 5 y5 years | - | 0.0% | 0.0% |
CASI Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -21.4% | +12.3% | -48.9% | +128.6% | -49.5% | at low |
| 5 y | 5-year | -21.4% | +720.1% | -48.9% | +479.8% | -49.5% | +433.9% |
| alltime | all time | -21.4% | >+9999.0% | -48.9% | >+9999.0% | -49.5% | >+9999.0% |
CASI Pharmaceuticals Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $7.79 M(+95.9%) | $22.05 M(-4.5%) |
| Jun 2024 | - | $3.98 M(+16.7%) | $23.10 M(-20.2%) |
| Mar 2024 | - | $3.41 M(-50.4%) | $28.94 M(-14.6%) |
| Dec 2023 | $33.88 M(-21.4%) | $6.87 M(-22.2%) | $33.88 M(-19.8%) |
| Sep 2023 | - | $8.84 M(-10.0%) | $42.26 M(-3.2%) |
| Jun 2023 | - | $9.82 M(+17.6%) | $43.64 M(+2.9%) |
| Mar 2023 | - | $8.35 M(-45.3%) | $42.39 M(-1.7%) |
| Dec 2022 | $43.11 M(+42.9%) | $15.26 M(+49.4%) | $43.11 M(+16.5%) |
| Sep 2022 | - | $10.21 M(+19.1%) | $37.01 M(+6.0%) |
| Jun 2022 | - | $8.57 M(-5.4%) | $34.91 M(+4.2%) |
| Mar 2022 | - | $9.06 M(-1.0%) | $33.49 M(+11.0%) |
| Dec 2021 | $30.17 M(+99.2%) | $9.16 M(+12.9%) | $30.17 M(+16.8%) |
| Sep 2021 | - | $8.11 M(+13.3%) | $25.83 M(+17.6%) |
| Jun 2021 | - | $7.16 M(+24.9%) | $21.96 M(+25.7%) |
| Mar 2021 | - | $5.74 M(+19.0%) | $17.47 M(+15.4%) |
| Dec 2020 | $15.14 M(+266.5%) | $4.82 M(+13.7%) | $15.14 M(+29.8%) |
| Sep 2020 | - | $4.24 M(+58.8%) | $11.66 M(+14.3%) |
| Jun 2020 | - | $2.67 M(-21.6%) | $10.21 M(+35.4%) |
| Mar 2020 | - | $3.41 M(+153.4%) | $7.54 M(+82.4%) |
| Dec 2019 | $4.13 M(+8560.4%) | $1.34 M(-51.8%) | $4.13 M(+48.2%) |
| Sep 2019 | - | $2.79 M(>+9900.0%) | $2.79 M(+3803.4%) |
| Dec 2015 | $47.70 K(+101.3%) | - | - |
| Jun 2015 | - | $24.00 K(+1.3%) | $71.40 K(+50.6%) |
| Mar 2015 | - | $23.70 K(0.0%) | $47.40 K(+100.0%) |
| Dec 2014 | $23.70 K(-96.5%) | $23.70 K(-96.5%) | $23.70 K(-96.5%) |
| Dec 2012 | $669.30 K(-65.5%) | $669.30 K(-65.4%) | $669.30 K(-65.5%) |
| Dec 2011 | $1.94 M(-47.4%) | $1.93 M(>+9900.0%) | $1.94 M(-47.6%) |
| Jun 2011 | - | $8900.00(-99.8%) | $3.70 M(+0.2%) |
| Dec 2010 | $3.69 M(-30.1%) | $3.69 M(+128.6%) | $3.69 M(-30.1%) |
| Dec 2009 | $5.28 M(-29.3%) | $1.62 M(-56.0%) | $5.28 M(-30.9%) |
| Sep 2009 | - | $3.67 M(-7.7%) | $7.64 M(+2.2%) |
| Dec 2008 | $7.48 M(+1.1%) | $3.98 M(+13.6%) | $7.48 M(+1.4%) |
| Sep 2008 | - | $3.50 M(-9.7%) | $7.38 M(-0.3%) |
| Dec 2007 | $7.40 M(+7.3%) | $3.88 M(+10.1%) | $7.40 M(+0.1%) |
| Sep 2007 | - | $3.52 M(-9.1%) | $7.39 M(+7.2%) |
| Dec 2006 | $6.89 M(+16.5%) | $3.87 M(+28.0%) | $6.89 M(-2.7%) |
| Sep 2006 | - | $3.02 M(-25.6%) | $7.09 M(+19.8%) |
| Dec 2005 | $5.92 M | $4.06 M(+225.2%) | $5.92 M(+197.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2005 | - | $1.25 M(+115.6%) | $1.99 M(+125.6%) |
| Jun 2005 | - | $579.50 K(+2199.6%) | $881.30 K(+99.8%) |
| Mar 2005 | - | $25.20 K(-81.2%) | $441.20 K(-14.2%) |
| Dec 2004 | $514.00 K(-67.4%) | $133.90 K(-6.2%) | $514.00 K(-42.7%) |
| Sep 2004 | - | $142.70 K(+2.4%) | $897.60 K(-11.4%) |
| Jun 2004 | - | $139.40 K(+42.2%) | $1.01 M(-12.6%) |
| Mar 2004 | - | $98.00 K(-81.1%) | $1.16 M(-26.4%) |
| Dec 2003 | $1.58 M(+33.9%) | $517.50 K(+100.2%) | $1.58 M(+3.7%) |
| Sep 2003 | - | $258.50 K(-9.6%) | $1.52 M(-5.4%) |
| Jun 2003 | - | $286.00 K(-44.3%) | $1.61 M(-1.4%) |
| Mar 2003 | - | $513.50 K(+11.2%) | $1.63 M(+38.6%) |
| Dec 2002 | $1.18 M(-36.8%) | $461.80 K(+33.6%) | $1.18 M(+39.4%) |
| Sep 2002 | - | $345.60 K(+11.8%) | $844.20 K(+43.2%) |
| Jun 2002 | - | $309.20 K(+416.2%) | $589.60 K(-43.2%) |
| Mar 2002 | - | $59.90 K(-53.7%) | $1.04 M(-44.3%) |
| Dec 2001 | $1.86 M(-49.3%) | $129.50 K(+42.3%) | $1.86 M(-37.0%) |
| Sep 2001 | - | $91.00 K(-88.0%) | $2.96 M(-20.5%) |
| Jun 2001 | - | $757.50 K(-14.3%) | $3.72 M(-2.9%) |
| Mar 2001 | - | $884.00 K(-27.8%) | $3.83 M(+4.3%) |
| Dec 2000 | $3.67 M(-26.8%) | $1.22 M(+43.3%) | $3.67 M(+28.1%) |
| Sep 2000 | - | $854.20 K(-1.5%) | $2.87 M(-24.8%) |
| Jun 2000 | - | $866.90 K(+19.3%) | $3.81 M(-10.8%) |
| Mar 2000 | - | $726.70 K(+74.0%) | $4.27 M(-14.4%) |
| Dec 1999 | $5.02 M(-3.5%) | $417.60 K(-76.8%) | $4.99 M(-17.8%) |
| Sep 1999 | - | $1.80 M(+35.4%) | $6.07 M(+9.0%) |
| Jun 1999 | - | $1.33 M(-8.0%) | $5.57 M(+2.4%) |
| Mar 1999 | - | $1.44 M(-3.7%) | $5.44 M(+4.7%) |
| Dec 1998 | $5.20 M(+8.3%) | $1.50 M(+15.4%) | $5.20 M(+2.0%) |
| Sep 1998 | - | $1.30 M(+8.3%) | $5.10 M(+2.0%) |
| Jun 1998 | - | $1.20 M(0.0%) | $5.00 M(+2.0%) |
| Mar 1998 | - | $1.20 M(-14.3%) | $4.90 M(+2.1%) |
| Dec 1997 | $4.80 M(+4.3%) | $1.40 M(+16.7%) | $4.80 M(+2.1%) |
| Sep 1997 | - | $1.20 M(+9.1%) | $4.70 M(+2.2%) |
| Jun 1997 | - | $1.10 M(0.0%) | $4.60 M(0.0%) |
| Mar 1997 | - | $1.10 M(-15.4%) | $4.60 M(0.0%) |
| Dec 1996 | $4.60 M | $1.30 M(+18.2%) | $4.60 M(+39.4%) |
| Sep 1996 | - | $1.10 M(0.0%) | $3.30 M(+50.0%) |
| Jun 1996 | - | $1.10 M(0.0%) | $2.20 M(+100.0%) |
| Mar 1996 | - | $1.10 M | $1.10 M |
FAQ
- What is CASI Pharmaceuticals annual revenue?
- What is the all time high annual revenue for CASI Pharmaceuticals?
- What is CASI Pharmaceuticals annual revenue year-on-year change?
- What is CASI Pharmaceuticals quarterly revenue?
- What is the all time high quarterly revenue for CASI Pharmaceuticals?
- What is CASI Pharmaceuticals quarterly revenue year-on-year change?
- What is CASI Pharmaceuticals TTM revenue?
- What is the all time high TTM revenue for CASI Pharmaceuticals?
- What is CASI Pharmaceuticals TTM revenue year-on-year change?
What is CASI Pharmaceuticals annual revenue?
The current annual revenue of CASI is $33.88 M
What is the all time high annual revenue for CASI Pharmaceuticals?
CASI Pharmaceuticals all-time high annual revenue is $43.11 M
What is CASI Pharmaceuticals annual revenue year-on-year change?
Over the past year, CASI annual revenue has changed by -$9.23 M (-21.41%)
What is CASI Pharmaceuticals quarterly revenue?
The current quarterly revenue of CASI is $7.79 M
What is the all time high quarterly revenue for CASI Pharmaceuticals?
CASI Pharmaceuticals all-time high quarterly revenue is $15.26 M
What is CASI Pharmaceuticals quarterly revenue year-on-year change?
Over the past year, CASI quarterly revenue has changed by $0.00 (0.00%)
What is CASI Pharmaceuticals TTM revenue?
The current TTM revenue of CASI is $22.05 M
What is the all time high TTM revenue for CASI Pharmaceuticals?
CASI Pharmaceuticals all-time high TTM revenue is $43.64 M
What is CASI Pharmaceuticals TTM revenue year-on-year change?
Over the past year, CASI TTM revenue has changed by $0.00 (0.00%)